Skip to main content
SpringerLink
Log in

Challenges with CEA models of HPV vaccination in LMICs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. National Health Service

Reference

  • Ekwunife OI, et al. Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations. PharmacoEconomics : 16 Sep 2016. Available from: URL: http://dx.doi.org/10.1007/s40273-016-0451-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Challenges with CEA models of HPV vaccination in LMICs. PharmacoEcon Outcomes News 763, 10 (2016). https://doi.org/10.1007/s40274-016-3423-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3423-4

Search

Navigation